BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Domperidone

A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.

299+ PubMed studies analyzed · 55 RCTs · Evidence Score: 53.3

Research Domains

Domperidone has been studied across 17 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 🦠 Gut & Microbiome, ❤️ Cardiovascular, 🧠 Neuroprotection. The primary research focus is 🧠 Focus & Attention with 36% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Domperidone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Maprotiline
33 shared targets
Amoxapine
36 shared targets
Nortriptyline
34 shared targets
Promethazine
30 shared targets
Dihydroergotamine
25 shared targets
Quetiapine
25 shared targets
Cinnarizine
24 shared targets
Cyproheptadine
30 shared targets
Trazodone
20 shared targets
Flunarizine
28 shared targets
Loading evidence profile...

This evidence profile for Domperidone is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.